Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q4 FY24 results · Jan–Mar 2024
Dr. Lal Path Labs reported revenue from operations of ₹545.40 crore (up 11.1% from Q4 FY23) and net profit of ₹85.80 crore (up 50.8% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 545.40 | 491.00 | +11.1% | 538.90 | +1.2% |
| Other income | 18.40 | 14.20 | +29.6% | 18.30 | +0.5% |
| Total income | 563.80 | 505.20 | +11.6% | 557.20 | +1.2% |
| Profit before tax | 119.90 | 83.20 | +44.1% | 115.90 | +3.5% |
| Net profit for the period | 85.80 | 56.90 | +50.8% | 82.20 | +4.4% |
| Attributable to shareholders of the company | 84.50 | 56.70 | +49.0% | 81.30 | +3.9% |
| EPS, basic (₹) | 10.13 | 6.84 | +48.1% | 9.77 | +3.7% |
| Net margin (%) | 15.7 | 11.6 | 15.3 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 479.00 | 431.00 | +11.1% | 476.00 | +0.6% |
| Other income | 15.90 | 11.60 | +37.1% | 15.10 | +5.3% |
| Total income | 494.90 | 442.60 | +11.8% | 491.10 | +0.8% |
| Profit before tax | 120.50 | 98.10 | +22.8% | 119.50 | +0.8% |
| Net profit for the period | 89.50 | 71.40 | +25.4% | 88.30 | +1.4% |
| EPS, basic (₹) | 10.73 | 8.61 | +24.6% | 10.78 | −0.5% |
| Net margin (%) | 18.7 | 16.6 | 18.6 |
Consolidated
- Filed with BSE
- 11 May 2024, 10:42 IST
- Board meeting
- 10 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 May 2024, 10:42 IST
- Board meeting
- 10 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE